Collaboration for diabetes research

摘要

Thermo Fisher Scientific and Nuclea Biotechnologies are to collaborate to accelerate translation of multiplexed methods to quantify type 2 diabetes markers. The pair will pool their expertise to develop methods for high-ffiroughput quantification of native insulin and its therapeutic analgoues. By monitoring levels of these biomarkers it might be possible to predict the response to therapy for the disease.